Lab-grown food could be sold in the UK within two years
Lab-grown food could be sold in the UK within two years, a watchdog has indicated.
The Food Standards Agency (FSA) said it was committed to completing the full safety assessment of two cell-cultivated products (CCPs) within the next two years.
The watchdog has launched a 'pioneering' regulatory programme for CCPs to make sure they are safe for consumers before they are sold, funded by the Department of Science, Innovation and Technology's Engineering Biology Sandbox Fund.
CCPs are new food products made without traditional farming methods such as rearing livestock or growing plants and grains.
Instead, cells from plants or animals are grown in a controlled environment to make the product.
There are currently no CCPs approved for human consumption in the UK.
FSA chief scientific adviser Professor Robin May said: 'Safe innovation is at the heart of this programme.
'By prioritising consumer safety and making sure new foods, like CCPs, are safe we can support growth in innovative sectors.
'Our aim is to ultimately provide consumers with a wider choice of new food, while maintaining the highest safety standards.'
A team of scientists and regulatory experts will work with academic bodies, the CCP industry and trade organisations on the two-year programme.
Science minister Lord Vallance said: 'By supporting the safe development of cell-cultivated products, we're giving businesses the confidence to innovate and accelerating the UK's position as a global leader in sustainable food production.
'This work will not only help bring new products to market faster, but strengthen consumer trust, supporting our Plan for Change and creating new economic opportunities across the country.'
The businesses participating in the programme are Hoxton Farms, Roslin Technologies and Uncommon Bio, all from the UK, BlueNalu (US), Mosa Meat (the Netherlands), Gourmey and Vital Meat (France) and Vow (Australia).
Hoxton Farms was launched in 2020 by Ed Steele and Max Jamilly, and has been pioneering technology to grow animal fat products that 'look, cook and taste like the real thing'.
Roslin Technologies was launched two years later as a biotech company to produce lab-grown pet food.
In February, a dog treat made from cultivated meat went on sale at Pets at Home in a move the retailer claimed was a world first.
In July last year, the UK became the first country in Europe to back cultivated meat for use in pet food, after chicken produced by the firm Meatly was approved by the Department for Environment, Food and Rural Affairs and the Animal and Plant Health Agency.
The treat, called Chick Bites, is made from plant-based ingredients combined with cultivated meat, which is produced by growing cells and does not require the raising or slaughter of animals.
Meatly said the chicken was produced from a single sample of cells taken from one chicken egg, from which enough cultivated meat could be produced to feed pets 'forever'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Spectator
4 hours ago
- Spectator
Is Xi Jinping's time up?
Stories about Xi Jinping's father, Xi Zhongxun, are blowing up on social media. He died in 2002, so why the interest in him now? The weird fact is that Xi Zhongxun is being talked about in the West because he is not being talked about in China. Omission is the perverse way that one learns about what is really going on in the opaque world of Chinese Communist party (CCP) politics. China-watchers live on scraps. Xi Zhongxun was a big cheese in his own right. Born in the north-west's Shaanxi province, he was an early member of the youth league of the CCP. After meeting Mao Zedong at the conclusion of the Long March, which ended up in his home province, he quickly rose through the party ranks. After making a success of his governorship of Guangdong Province, where he set up one of the first of Deng Xiaoping's 'Special Economic Zones', Xi Zhongxun was promoted to the politburo in 1982. His official obituary describes him as 'an outstanding proletarian revolutionary', who was 'one of the main founders and leaders of the revolutionary base areas in the Shanxi-Gansu border region'. In short, Xi Zhongxun was an early hero and 'big beast' of the CCP. He passed his 'red genes' on to Xi Jinping, the primus inter pares of the 'princelings' who have come to dominate China's politics over the past decade. As such, it was no surprise that at the recent inauguration of the Revolutionary Memorial Hall in Shaanxi, it was planned to name it after Xi Zhongxun. But it didn't happen. At the last minute, in a low-key ceremony, his name was not only expunged from the title but omitted entirely from the memorial. A similarly strange story attaches to the 40-episode drama series Time in the Northwest, which followed Xi Zhongxun's life story. This unashamed glorification of President Xi's family, slated to be shown in primetime on CCTV, China's main state broadcaster, was dropped after two episodes. Is it a coincidence that the expunging of Xi Zhongxun has come to light while Xi himself seemingly disappeared from public view in the last two weeks of May? Chinese institutions are always alert to changes in the political wind – no more so than the state media. Recently China-watchers have detected subtle changes. Xi, usually on every front page of the People's Liberation Army Daily, has been much less prominent. Shen Ming-Shih, a director of the Institute for National Defence and Security Research in Taiwan, has observed 'a noticeable decline in the official references to Xi'. In the past, Xi has been described as the 'eternal core of the party'. As recently as December, the People's Liberation Army Daily wrote that decisions should 'rely on a single voice of authority'. Now it praises the virtues of 'collective leadership'. In addition, Shen has pointed out that academics at Peking University and South China University of Technology have not been punished for writing essays critical of Xi's policies. Remarkably, Hu Jintao, Xi's predecessor and faction opponent, who, in front of the world's press, was humiliatingly manhandled out of the CCP's 20th National Congress in October 2022 by Xi's bodyguards, seems to be making a comeback. On 19 May, the People's Daily and Xinhua News both published articles using Hu catchphrases that reference 'scientific, democratic and law-based decision-making'. Wen Jiabao, the supposedly billionaire former Chinese premier, is another elder who is reportedly on manoeuvres. In May, the usual monthly politburo meeting did not take place. Furthermore, Xi has not been present at high-level meetings of the Central Military Commission (CMC) of which he is chairman. His place has been taken by General Zhang, who is not a Xi faction member. CMC chairmanship is central to the power of a CCP General Secretary. CCP elders are disillusioned by a leader who has assumed dictatorial powers but is deemed to have failed Uncertainty about the direction of the People's Liberation Army has contributed to the rumours of change in China's leadership. Hei Weidong, vice-chairman of the CMC and a member of Xi's Fujian faction, was suddenly arrested in April. Xi was governor of Fujian Province in the late 1990s. In November last year, another of Xi's Fujian clique, Admiral Miao Hua, who was head of the CMC's Political Work Department, was put under investigation for 'serious violations of discipline' – the usual newspeak for corruption. On 30 April, he was dismissed. Other Xi generals have reportedly been removed from their posts. In the realm of economic management there are also signs of discontent. It is widely recognised that Xi's repressive handling of the Covid pandemic was catastrophic. In the end it was public protest that forced him to end lockdown. By Chinese standards, post-Covid recovery has been anaemic. A property crash has destroyed consumer confidence and has also landed provincial governments with unsustainable levels of debt. Graduate unemployment has risen sharply. Many are fleeing to the West to find employment. A sense of malaise has cast a pall over China's younger generations. As a recent émigré Chinese dissident, who, like her friends, disparagingly refers to Xi as 'the village headman', confided to me: 'I realise that I was fortunate to live in a golden age of freedom and prosperity. Now it is over.' A sign of Xi's diminishing power is the increasing redundancy of the economic posts he held. The Central Financial and Economic Affairs Commission, which he chairs, has been meeting only sporadically. Foreign direct investment (FDI), which was a main contributor to the explosive economic growth of China after Deng's liberalisation of the economy in the 1980s, has collapsed. Beijing's State Administration of Foreign Exchange reported that FDI in 2023 was the lowest for 30 years. Inevitably a high proportion of blame for capital flight is being put on Xi's 'wolf-warrior' approach to diplomacy, itself an abandonment of Deng's 'softly, softly' approach to the expansion of China's global power. Who has been moving against Xi? Apart from elements within the army, who are thought to oppose military action against Taiwan, the 'princelings', many of whose offspring now reside overseas with the billions that their families have squirrelled away, are thought to be conspiring against the President. Most importantly, the party elders are disillusioned by a leader who has assumed dictatorial powers but is deemed to have failed. In China the elders act like an informal Areopagus, which in extremis checks the power of the executive. Willy Wo-Lap Lam, a Hong Kong-based scholar, has concluded that Xi's 'ability to shape policy in the financial, foreign affairs and other arenas has been truncated'. Lam speculates that 'Xi might be driven out of office this year'. Similarly, Cai Shenkun, a long-standing China-watcher, has reported that CCP leaders have already decided that Xi must step down: 'It's almost certain that an arrangement will be made to allow Xi and his inner circle to withdraw gracefully from the political stage. Once new leadership takes over, a new approach to governance will follow.' In a similar vein, Yao Cheng, a former officer in the CCP navy who deserted and fled to America in 2016, has speculated that Xi will retain 'only the ceremonial title of China's Chairman, before fully retiring at the 21st National Congress [in 2027]'. Xi's two-week disappearance in May seemed to support the theory that he has already been frozen out. So, did his reappearance on 4 June when he met Belarus leader Alexander Lukashenko lay to rest the rumours of his political demise? Quite the opposite. The meeting, which was abnormally held in Xi's house, was strangely subfusc and devoid of normal protocols. Reporting was delayed and brief and did not feature any quotations from the President. The press photographs were lifted from Belarusian media as though Chinese reporters and photographers were not allowed to be present. If the rumours of Xi's defenestration are true, why the delay and subterfuge? The answer may lie in the fact that there is no obvious successor. No surprise here, seeing as, during his 12 years in power, Xi has put his clique in most senior positions. Zhang Lei, a well-connected, US-based YouTuber, has speculated that the CCP elders are casting around for a successor. Her sources suggest that Wang Yang, a liberal 'non-princeling' member of the Politburo Standing Committee of the CCP from 2017 to 2022, has been sounded out. The demise of Xi has been predicted before and there can be no certainty that the recent waves of rumours are accurate. Even if they are true, it remains possible that Xi could stage a comeback and put his enemies to flight. However, given the dire problems facing China and the indifferent performance of its leader, it seems quite plausible that forces within the CCP have had enough of the dictatorial Xi, who, just two years ago, had presumptuously declared his intention to rule until 2032. If Xi falls, or indeed has already fallen, the consequences for Taiwan and US-China relations could be dramatic – and possibly beneficial to both.
South Wales Guardian
5 hours ago
- South Wales Guardian
Reeves announces £6 billion to provide millions of NHS tests and procedures
New scanners, ambulances and urgent treatment centres are among the things which the additional cash will pay for, with the aim of providing up to four million more tests and procedures over the next five years. The announcement comes after the Chancellor put NHS funding at the heart of her spending review on Wednesday, raising its budget in a move worth £29 billion a year. This comes, however, at the expense of other areas of public spending. The new £6 billion funding will help to meet the Government's target of reducing NHS waiting lists in England, the Chancellor claimed. 'Over a decade of underinvestment from the previous government put the NHS on its knees, with people across the country unable to get the care they need. We are investing in Britain's renewal, and we will turn that around,' Ms Reeves said. She added: 'Part of our record investment will deliver four million tests, scans and procedures, so hard-working people can get the healthcare they and their families need. 'There is no strong economy without a strong NHS, and we'll deliver on our Plan for Change to end the hospital backlog, improve living standards and get more money in people's pockets.' The latest spending commitment will help patients get access to diagnostic scans and treatment in places such as shopping centres and high streets, speeding up their diagnoses. The Government hopes this will help to cut NHS waiting lists, meeting Labour's goal of ensuring the health service carries out 92% of routine operations within 18 weeks. Health Secretary Wes Streeting said: 'Since taking office we have been relentless in our drive to cut waiting times for patients, delivering over 3.6 million extra elective care appointments and reducing the overall waiting list by over 200,000. 'The £6 billion investment we are announcing today will generate millions more vital diagnostic tests, scans and procedures for patients across the country.' On Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after giving the NHS a 3% annual increase in funding at the spending review. Some health leaders are, however, sceptical that the Government will meet its target, despite the funding boost provided at the spending review. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Sarah Woolnough, chief executive of the King's Fund charity, said: 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times, more GP appointments, and adequate mental health services and more can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.'
South Wales Argus
5 hours ago
- South Wales Argus
Reeves announces £6 billion to provide millions of NHS tests and procedures
New scanners, ambulances and urgent treatment centres are among the things which the additional cash will pay for, with the aim of providing up to four million more tests and procedures over the next five years. The announcement comes after the Chancellor put NHS funding at the heart of her spending review on Wednesday, raising its budget in a move worth £29 billion a year. This comes, however, at the expense of other areas of public spending. The new £6 billion funding will help to meet the Government's target of reducing NHS waiting lists in England, the Chancellor claimed. 'Over a decade of underinvestment from the previous government put the NHS on its knees, with people across the country unable to get the care they need. We are investing in Britain's renewal, and we will turn that around,' Ms Reeves said. She added: 'Part of our record investment will deliver four million tests, scans and procedures, so hard-working people can get the healthcare they and their families need. 'There is no strong economy without a strong NHS, and we'll deliver on our Plan for Change to end the hospital backlog, improve living standards and get more money in people's pockets.' The latest spending commitment will help patients get access to diagnostic scans and treatment in places such as shopping centres and high streets, speeding up their diagnoses. The Government hopes this will help to cut NHS waiting lists, meeting Labour's goal of ensuring the health service carries out 92% of routine operations within 18 weeks. Health Secretary Wes Streeting said: 'Since taking office we have been relentless in our drive to cut waiting times for patients, delivering over 3.6 million extra elective care appointments and reducing the overall waiting list by over 200,000. 'The £6 billion investment we are announcing today will generate millions more vital diagnostic tests, scans and procedures for patients across the country.' On Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after giving the NHS a 3% annual increase in funding at the spending review. Chancellor of the Exchequer Rachel Reeves during a visit to St Thomas' Hospital in London, following the spending review (Carl Court/PA) Some health leaders are, however, sceptical that the Government will meet its target, despite the funding boost provided at the spending review. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Sarah Woolnough, chief executive of the King's Fund charity, said: 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times, more GP appointments, and adequate mental health services and more can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.'
